Immunogenicity and Safety of a Booster Dose of Monovalent Glycoprotein-Conjugated (Diptheria Toxin -CRM197) Hib Vaccine in 365-569 Days Old Healthy Infants

Clinical trial NCT01226953 · COMPLETED

Trial details

NCT number: NCT01226953
Sponsor: Novartis Vaccines
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Haemophilus Influenzae Type b (Hib) Infection

Start date: 2010-10-01
Primary completion: 2010-12-01
Enrollment: 660

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.